PubRank

Henrik Grönberg

Author PubWeight™ 233.50‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet 2010 23.08
2 Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 2010 20.01
3 Cumulative association of five genetic variants with prostate cancer. N Engl J Med 2008 15.34
4 Inflammation in prostate carcinogenesis. Nat Rev Cancer 2007 9.08
5 Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J Med 2014 6.89
6 Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP. J Natl Cancer Inst 2007 4.85
7 GWAS of 126,559 individuals identifies genetic variants associated with educational attainment. Science 2013 4.71
8 Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat Genet 2013 3.25
9 Evidence for two independent prostate cancer risk-associated loci in the HNF1B gene at 17q12. Nat Genet 2008 3.14
10 Sex-stratified genome-wide association studies including 270,000 individuals show sexual dimorphism in genetic loci for anthropometric traits. PLoS Genet 2013 2.83
11 FTO genotype is associated with phenotypic variability of body mass index. Nature 2012 2.77
12 Risk of ovarian cancer in breast-cancer patients with a family history of breast or ovarian cancer: a population-based cohort study. Lancet 2002 2.72
13 Polygenic risk score improves prostate cancer risk prediction: results from the Stockholm-1 cohort study. Eur Urol 2011 2.62
14 Genome-wide association study identifies new prostate cancer susceptibility loci. Hum Mol Genet 2011 2.51
15 Sequence variants at 22q13 are associated with prostate cancer risk. Cancer Res 2009 2.27
16 HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG). Hum Genet 2012 2.18
17 The mutational landscape of prostate cancer. Eur Urol 2013 2.14
18 Risk of renal cell carcinoma after hysterectomy. Arch Intern Med 2010 2.12
19 Estimation of absolute risk for prostate cancer using genetic markers and family history. Prostate 2009 1.99
20 Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer Prostate in Sweden Study. Cancer Res 2004 1.91
21 Familial concordance in cancer survival: a Swedish population-based study. Lancet Oncol 2007 1.90
22 Fine mapping association study and functional analysis implicate a SNP in MSMB at 10q11 as a causal variant for prostate cancer risk. Hum Mol Genet 2009 1.90
23 Two independent prostate cancer risk-associated Loci at 11q13. Cancer Epidemiol Biomarkers Prev 2009 1.78
24 Prostate-specific antigen (PSA) testing is prevalent and increasing in Stockholm County, Sweden, Despite no recommendations for PSA screening: results from a population-based study, 2003-2011. Eur Urol 2012 1.74
25 Association of prostate cancer risk variants with clinicopathologic characteristics of the disease. Clin Cancer Res 2008 1.74
26 Pooled genome linkage scan of aggressive prostate cancer: results from the International Consortium for Prostate Cancer Genetics. Hum Genet 2006 1.70
27 Women with Saethre-Chotzen syndrome are at increased risk of breast cancer. Genes Chromosomes Cancer 2007 1.66
28 Causes of death in the Sami population of Sweden, 1961-2000. Int J Epidemiol 2005 1.60
29 Exome sequencing of prostate cancer supports the hypothesis of independent tumour origins. Eur Urol 2012 1.60
30 Inherited genetic variant predisposes to aggressive but not indolent prostate cancer. Proc Natl Acad Sci U S A 2010 1.59
31 Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk. J Natl Cancer Inst 2005 1.55
32 A population-based assessment of germline HOXB13 G84E mutation and prostate cancer risk. Eur Urol 2012 1.55
33 Cumulative effect of five genetic variants on prostate cancer risk in multiple study populations. Prostate 2008 1.53
34 Macrophage inhibitory cytokine 1: a new prognostic marker in prostate cancer. Clin Cancer Res 2009 1.51
35 A novel prostate cancer susceptibility locus at 19q13. Cancer Res 2009 1.49
36 A support vector machine approach for detecting gene-gene interaction. Genet Epidemiol 2008 1.46
37 The interaction of four genes in the inflammation pathway significantly predicts prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2005 1.39
38 Blood biomarker levels to aid discovery of cancer-related single-nucleotide polymorphisms: kallikreins and prostate cancer. Cancer Prev Res (Phila) 2010 1.35
39 Association of reported prostate cancer risk alleles with PSA levels among men without a diagnosis of prostate cancer. Prostate 2009 1.33
40 Genetic analysis of the RNASEL gene in hereditary, familial, and sporadic prostate cancer. Clin Cancer Res 2004 1.32
41 Macrophage inhibitory cytokine-1 (MIC-1/GDF15): a new marker of all-cause mortality. Aging Cell 2010 1.29
42 Association of a germ-line copy number variation at 2p24.3 and risk for aggressive prostate cancer. Cancer Res 2009 1.29
43 Genetic variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF genes are prognostic markers of prostate cancer-specific mortality. Cancer Epidemiol Biomarkers Prev 2011 1.28
44 H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer. J Natl Cancer Inst 2004 1.26
45 Genetic markers associated with early cancer-specific mortality following prostatectomy. Cancer 2013 1.25
46 Established prostate cancer susceptibility variants are not associated with disease outcome. Cancer Epidemiol Biomarkers Prev 2009 1.24
47 Association between sequence variants at 17q12 and 17q24.3 and prostate cancer risk in European and African Americans. Prostate 2008 1.24
48 Interaction between single nucleotide polymorphisms in selenoprotein P and mitochondrial superoxide dismutase determines prostate cancer risk. Cancer Res 2008 1.22
49 Familial brain tumours-genetics or environment? A nationwide cohort study of cancer risk in spouses and first-degree relatives of brain tumour patients. Int J Cancer 2003 1.21
50 Inherited genetic markers discovered to date are able to identify a significant number of men at considerably elevated risk for prostate cancer. Prostate 2010 1.20
51 A systematic overview of radiation therapy effects in rectal cancer. Acta Oncol 2003 1.20
52 Compelling evidence for a prostate cancer gene at 22q12.3 by the International Consortium for Prostate Cancer Genetics. Hum Mol Genet 2007 1.20
53 Systematic replication study of reported genetic associations in prostate cancer: Strong support for genetic variation in the androgen pathway. Prostate 2006 1.19
54 Fine mapping of a region of chromosome 11q13 reveals multiple independent loci associated with risk of prostate cancer. Hum Mol Genet 2011 1.17
55 Association of frequent consumption of fatty fish with prostate cancer risk is modified by COX-2 polymorphism. Int J Cancer 2007 1.15
56 Genome-wide scan of Swedish families with hereditary prostate cancer: suggestive evidence of linkage at 5q11.2 and 19p13.3. Prostate 2003 1.15
57 A comprehensive association study for genes in inflammation pathway provides support for their roles in prostate cancer risk in the CAPS study. Prostate 2006 1.15
58 Ovarian cancer linked to Lynch syndrome typically presents as early-onset, non-serous epithelial tumors. Gynecol Oncol 2011 1.14
59 Adjuvant chemotherapy in colorectal cancer: a joint analysis of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group. Acta Oncol 2005 1.13
60 The mitochondrial and autosomal mutation landscapes of prostate cancer. Eur Urol 2012 1.12
61 Clinical characterization and the mutation spectrum in Swedish adenomatous polyposis families. BMC Med 2008 1.12
62 Interactions of sequence variants in interleukin-1 receptor-associated kinase4 and the toll-like receptor 6-1-10 gene cluster increase prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2006 1.10
63 Genetic variants and family history predict prostate cancer similar to prostate-specific antigen. Clin Cancer Res 2009 1.09
64 Hypermethylation of the GABRE~miR-452~miR-224 promoter in prostate cancer predicts biochemical recurrence after radical prostatectomy. Clin Cancer Res 2014 1.08
65 NordicDB: a Nordic pool and portal for genome-wide control data. Eur J Hum Genet 2010 1.07
66 Implications for prostate cancer of insulin-like growth factor-I (IGF-I) genetic variation and circulating IGF-I levels. J Clin Endocrinol Metab 2007 1.06
67 Evaluation of association of HNF1B variants with diverse cancers: collaborative analysis of data from 19 genome-wide association studies. PLoS One 2010 1.05
68 The genetic structure of the Swedish population. PLoS One 2011 1.05
69 Sequence variants in the TLR4 and TLR6-1-10 genes and prostate cancer risk. Results based on pooled analysis from three independent studies. Cancer Epidemiol Biomarkers Prev 2010 1.05
70 Dietary phytoestrogen, serum enterolactone and risk of prostate cancer: the cancer prostate Sweden study (Sweden). Cancer Causes Control 2006 1.05
71 Genetic variability in inflammation pathways and prostate cancer risk. Urol Oncol 2007 1.00
72 Refining the prostate cancer genetic association within the JAZF1 gene on chromosome 7p15.2. Cancer Epidemiol Biomarkers Prev 2010 0.99
73 Breast cancer as a second primary in patients with prostate cancer--estrogen treatment or association with family history of cancer? J Urol 2006 0.99
74 Toward next generation plasma profiling via heat-induced epitope retrieval and array-based assays. Mol Cell Proteomics 2010 0.99
75 Estrogen receptor beta polymorphism is associated with prostate cancer risk. Clin Cancer Res 2006 0.99
76 Analysis of lipid pathway genes indicates association of sequence variation near SREBF1/TOM1L2/ATPAF2 with dementia risk. Hum Mol Genet 2010 0.99
77 Different aetiology of familial low-grade and high-grade glioma? A nationwide cohort study of familial glioma. Neuroepidemiology 2002 0.99
78 Toll-like receptor signaling pathway variants and prostate cancer mortality. Cancer Epidemiol Biomarkers Prev 2009 0.99
79 The UGT2B17 gene deletion is not associated with prostate cancer risk. Prostate 2008 0.98
80 Genetic variation in p53 and ATM haplotypes and risk of glioma and meningioma. J Neurooncol 2006 0.97
81 Validation of prostate cancer risk-related loci identified from genome-wide association studies using family-based association analysis: evidence from the International Consortium for Prostate Cancer Genetics (ICPCG). Hum Genet 2011 0.97
82 Germ-line genetic variation in the key androgen-regulating genes androgen receptor, cytochrome P450, and steroid-5-alpha-reductase type 2 is important for prostate cancer development. Cancer Res 2006 0.94
83 The European Parliament proposal for the new EU General Data Protection Regulation may severely restrict European epidemiological research. Eur J Epidemiol 2014 0.94
84 Novel findings in Swedish patients with MYH-associated polyposis: mutation detection and clinical characterization. Clin Gastroenterol Hepatol 2006 0.93
85 Association analysis of 9,560 prostate cancer cases from the International Consortium of Prostate Cancer Genetics confirms the role of reported prostate cancer associated SNPs for familial disease. Hum Genet 2013 0.93
86 Lactase persistence, dietary intake of milk, and the risk for prostate cancer in Sweden and Finland. Cancer Epidemiol Biomarkers Prev 2007 0.93
87 Inherited variation in hormone-regulating genes and prostate cancer survival. Clin Cancer Res 2007 0.91
88 Comparison of two methods for estimating absolute risk of prostate cancer based on single nucleotide polymorphisms and family history. Cancer Epidemiol Biomarkers Prev 2010 0.91
89 Coffee and risk of prostate cancer incidence and mortality in the Cancer of the Prostate in Sweden Study. Cancer Causes Control 2013 0.90
90 Dietary intake of phytoestrogens, estrogen receptor-beta polymorphisms and the risk of prostate cancer. Prostate 2006 0.90
91 Cancer in the Sami population of Sweden in relation to lifestyle and genetic factors. Eur J Epidemiol 2008 0.90
92 Identification of genomic deletions of the APC gene in familial adenomatous polyposis by two independent quantitative techniques. Genet Test 2004 0.89
93 Germline mutations in E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer. Int J Cancer 2002 0.89
94 Second primary cancers in men with prostate cancer: an increased risk of male breast cancer. J Urol 2003 0.89
95 Library preparation and multiplex capture for massive parallel sequencing applications made efficient and easy. PLoS One 2012 0.88
96 Genome-wide linkage analysis of 1,233 prostate cancer pedigrees from the International Consortium for Prostate Cancer Genetics using novel sumLINK and sumLOD analyses. Prostate 2010 0.88
97 Genetic and plasma variation of insulin-like growth factor binding proteins in relation to prostate cancer incidence and survival. Prostate 2009 0.88
98 Fatal accidents and suicide among reindeer-herding Sami in Sweden. Int J Circumpolar Health 2004 0.88
99 Linkage analysis of prostate cancer susceptibility: confirmation of linkage at 8p22-23. Hum Genet 2003 0.88
100 Lifetime total physical activity and prostate cancer risk: a population-based case-control study in Sweden. Eur J Epidemiol 2008 0.87
101 Acrylamide exposure measured by food frequency questionnaire and hemoglobin adduct levels and prostate cancer risk in the Cancer of the Prostate in Sweden Study. Int J Cancer 2009 0.87
102 -160C/A polymorphism in the E-cadherin gene promoter and risk of hereditary, familial and sporadic prostate cancer. Int J Cancer 2004 0.87
103 Interleukin-6 sequence variants are not associated with prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2004 0.87
104 Mutation analysis of the MLH1, MSH2 and MSH6 genes in patients with double primary cancers of the colorectum and the endometrium: a population-based study in northern Sweden. Int J Cancer 2004 0.86
105 Rapid increase in multidrug-resistant enteric bacilli blood stream infection after prostate biopsy - A 10-year population-based cohort study. Prostate 2015 0.86
106 Alcohol drinking and risk of localized versus advanced and sporadic versus familial prostate cancer in Sweden. Cancer Causes Control 2005 0.86
107 A genome-wide assessment of variability in human serum metabolism. Hum Mutat 2013 0.86
108 Birth characteristics and risk of prostate cancer: the contribution of genetic factors. Cancer Epidemiol Biomarkers Prev 2009 0.86
109 Comprehensive evaluation of genetic variation in the IGF1 gene and risk of prostate cancer. Int J Cancer 2007 0.86
110 Comprehensive genetic evaluation of common E-cadherin sequence variants and prostate cancer risk: strong confirmation of functional promoter SNP. Hum Genet 2005 0.85
111 Analysis of the macrophage scavenger receptor 1 gene in Swedish hereditary and sporadic prostate cancer. Prostate 2004 0.85
112 Detection of Escherichia coli 16S RNA and cytotoxic necrotizing factor 1 gene in benign prostate hyperplasia. Eur Urol 2006 0.85
113 Genetic variation in the SST gene and its receptors in relation to circulating levels of insulin-like growth factor-I, IGFBP3, and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2009 0.84
114 The MTHFR 677C --> T polymorphism and risk of prostate cancer: results from the CAPS study. Cancer Causes Control 2007 0.83
115 Mutation screening of fumarate hydratase by multiplex ligation-dependent probe amplification: detection of exonic deletion in a patient with leiomyomatosis and renal cell cancer. Cancer Genet Cytogenet 2008 0.83
116 Body mass index and weight change in men with prostate cancer: progression and mortality. Cancer Causes Control 2014 0.82
117 Psychological aspects of screening in families with hereditary prostate cancer. Scand J Urol Nephrol 2003 0.82
118 Lifetime body size and prostate cancer risk in a population-based case-control study in Sweden. Cancer Causes Control 2013 0.82
119 MUC1 as a Putative Prognostic Marker for Prostate Cancer. Biomark Insights 2008 0.82
120 Genome-wide copy-number variation analysis identifies common genetic variants at 20p13 associated with aggressiveness of prostate cancer. Carcinogenesis 2011 0.82
121 Re: Zinc supplement use and risk of prostate cancer. J Natl Cancer Inst 2004 0.82
122 Chromosomes 4 and 8 implicated in a genome wide SNP linkage scan of 762 prostate cancer families collected by the ICPCG. Prostate 2011 0.81
123 A hypothesis-generating search for new genetic breast cancer syndromes--a national study in 803 Swedish families. Hered Cancer Clin Pract 2007 0.80
124 Fine-mapping and family-based association analyses of prostate cancer risk variants at Xp11. Cancer Epidemiol Biomarkers Prev 2009 0.79
125 Immunohistochemical profile of ductal adenocarcinoma of the prostate. Virchows Arch 2014 0.78
126 Early detection of prostate cancer with emphasis on genetic markers. Acta Oncol 2011 0.78
127 Prostate cancer risk variants are not associated with disease progression. Prostate 2011 0.78
128 Difference between Swedish and Japanese men in the association between AR CAG repeats and prostate cancer suggesting a susceptibility-modifying locus overlapping the androgen receptor gene. Int J Mol Med 2003 0.78
129 Risk of Prostate Cancer after Trans Urethral Resection of BPH: A Cohort and Nested Case-Control Study. Cancers (Basel) 2011 0.78
130 Haplotype-based analysis of common variation in the growth hormone receptor gene and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2007 0.78
131 Alcohol influence on acrylamide to glycidamide metabolism assessed with hemoglobin-adducts and questionnaire data. Food Chem Toxicol 2009 0.77
132 A multigenic approach to evaluating prostate cancer risk in a systematic replication study. Cancer Genet Cytogenet 2008 0.77
133 Analysis of Xq27-28 linkage in the international consortium for prostate cancer genetics (ICPCG) families. BMC Med Genet 2012 0.76
134 Does a low frequency of P53 and Pgp expression in familial glioma compared to sporadic controls indicate biological differences? Anticancer Res 2003 0.76
135 Genetic variation in the upstream region of ERG and prostate cancer. Cancer Causes Control 2009 0.75
136 Correction: The Influence of Age and Sex on Genetic Associations with Adult Body Size and Shape: A Large-Scale Genome-Wide Interaction Study. PLoS Genet 2016 0.75
137 The Nordic Nutrition Recommendations and prostate cancer risk in the Cancer of the Prostate in Sweden (CAPS) study. Public Health Nutr 2012 0.75
138 Germline mutation screening of the Saethre-Chotzen-associated genes TWIST1 and FGFR3 in families with BRCA1/2-negative breast cancer. Scand J Plast Reconstr Surg Hand Surg 2009 0.75
139 [Essential to discover hereditary colorectal and endometrial cancer. Mutations in "HNPCC individuals" can cause several different tumors]. Lakartidningen 2002 0.75
140 Reply from Authors re: Goutham Vemana, Gerald L. Andriole. Bad Habits May Be Hard to Break. Eur Urol 2013;63:426-7: Changing Habits. Eur Urol 2012 0.75